WO1998015293A3 - Apport cible de polymeres solubles a des proteines de recombinaison - Google Patents
Apport cible de polymeres solubles a des proteines de recombinaison Download PDFInfo
- Publication number
- WO1998015293A3 WO1998015293A3 PCT/US1997/018104 US9718104W WO9815293A3 WO 1998015293 A3 WO1998015293 A3 WO 1998015293A3 US 9718104 W US9718104 W US 9718104W WO 9815293 A3 WO9815293 A3 WO 9815293A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- soluble polymers
- recombinant proteins
- targeted addition
- protein
- modification
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97945549A EP1011730A2 (fr) | 1996-10-07 | 1997-10-07 | Apport cible de polymeres solubles a des proteines de recombinaison |
AU46722/97A AU4672297A (en) | 1996-10-07 | 1997-10-07 | Targeted addition of soluble polymers to recombinant proteins |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2809196P | 1996-10-07 | 1996-10-07 | |
US60/028,091 | 1996-10-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998015293A2 WO1998015293A2 (fr) | 1998-04-16 |
WO1998015293A3 true WO1998015293A3 (fr) | 1998-06-18 |
Family
ID=21841531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/018104 WO1998015293A2 (fr) | 1996-10-07 | 1997-10-07 | Apport cible de polymeres solubles a des proteines de recombinaison |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1011730A2 (fr) |
AU (1) | AU4672297A (fr) |
WO (1) | WO1998015293A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6540897B1 (en) * | 2000-07-13 | 2003-04-01 | Pierce Chemical Company | Direct detection of histidine tagged biomolecules on electrophoretic gel |
US7045283B2 (en) | 2000-10-18 | 2006-05-16 | The Regents Of The University Of California | Methods of high-throughput screening for internalizing antibodies |
CN108586291A (zh) * | 2018-01-02 | 2018-09-28 | 成都傲飞生物化学品有限责任公司 | 一种n,n-双(羧甲基)-l-赖氨酸的生产工艺 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993010233A1 (fr) * | 1991-11-11 | 1993-05-27 | Fidia S.P.A. | Synthese et purification des formes tronquees et proteiniques mutantes du facteur neurotrophique ciliaire de l'homme |
WO1995001797A1 (fr) * | 1993-07-09 | 1995-01-19 | Smithkline Beecham Corporation | Purification de proteines |
WO1996009805A2 (fr) * | 1994-09-23 | 1996-04-04 | Zonagen, Inc. | Immunostimulation induite par le chitosane |
-
1997
- 1997-10-07 WO PCT/US1997/018104 patent/WO1998015293A2/fr not_active Application Discontinuation
- 1997-10-07 AU AU46722/97A patent/AU4672297A/en not_active Abandoned
- 1997-10-07 EP EP97945549A patent/EP1011730A2/fr not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993010233A1 (fr) * | 1991-11-11 | 1993-05-27 | Fidia S.P.A. | Synthese et purification des formes tronquees et proteiniques mutantes du facteur neurotrophique ciliaire de l'homme |
WO1995001797A1 (fr) * | 1993-07-09 | 1995-01-19 | Smithkline Beecham Corporation | Purification de proteines |
WO1996009805A2 (fr) * | 1994-09-23 | 1996-04-04 | Zonagen, Inc. | Immunostimulation induite par le chitosane |
Non-Patent Citations (3)
Title |
---|
GERSHON P.D. ET AL: "Stable chelating linkage for reversible immobilization of oligohistidine tagged proteins in the BIAcore surface plasmon resonance detector", JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 183/1 SPEC. ISSUE (65-76), NETHERLANDS, XP004021026 * |
HOCHULI E. ET AL.: "New metal chelate adsorbent selective for proteins and peptides containing neighbouring histidine residues", J. CHROMATOGRAPHY, vol. 411, 1987, pages 177 - 184, XP002059738 * |
PORATH J. ET AL: "Metal chelate affinity chromatography, a new approach to protein fractionation", NATURE, vol. 258, 18 December 1975 (1975-12-18), pages 598 - 599, XP002059246 * |
Also Published As
Publication number | Publication date |
---|---|
EP1011730A2 (fr) | 2000-06-28 |
AU4672297A (en) | 1998-05-05 |
WO1998015293A2 (fr) | 1998-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE892974L (en) | Hydrophobic protein microparticles and preparation thereof | |
WO1990003123A3 (fr) | Micro-particules de proteine hydrophobe et leur preparation | |
CA2155185A1 (fr) | Reactifs par affinite, totalement synthetiques | |
CA2331337A1 (fr) | Modification de proteine specifique a un site par mutagenese | |
WO1999029882A3 (fr) | Procede permettant de modifier la valeur nutritive d'une proteine vegetale, la proteine de stockage vegetatif, en modifiant la teneur en acides amines des proteines | |
EP0377836A3 (fr) | Méthode et composition pour conditionner les cheveux | |
AU9174398A (en) | Peptides | |
AU6542598A (en) | Site protected protein modification | |
EP0782825A4 (fr) | Proteine de lactoserum modifiee et son procede de production | |
WO1993021331A3 (fr) | Conjugues et proteines fusionnees se liant aux polysaccharides | |
NO331199B1 (no) | Fremgangsmåter for fremvisning av (poly)peptider/proteiner på bakteriofagpartikler via disulfid bindinger, nukleinsyresekvens, vektor, vertscelle, modifiserte varianter av proteiner, bakteriofagpartikkel og variert samling av bakteriofagpartikler. | |
AU6776600A (en) | 2'-o-acetamido modified monomers and oligomers | |
WO2001007595A3 (fr) | Nouveau facteur de croissance des fibroblastes et acides nucleiques codant ce dernier | |
CA2075974A1 (fr) | Reactifs d'affinite entierement synthetiques | |
HK1143989A1 (en) | Conjugates prepared with aggregate-free proteins | |
CA2195076A1 (fr) | Procede de modification de la stabilite des anticorps | |
CA2019671A1 (fr) | Denaturation oxydative d'analytes proteiniques | |
WO1999037673A3 (fr) | Produit alimentaire congele | |
EP0754229A1 (fr) | L'alfamine, une proteine albuminoide serique humaine | |
WO1997029199A3 (fr) | Peptides pour l'antigene prostatique specifique et leurs utilisations | |
WO1998015293A3 (fr) | Apport cible de polymeres solubles a des proteines de recombinaison | |
WO1994025590A3 (fr) | Thrichohyaline et transglutaminase-3 et procedes d'utilisation | |
IL152406A0 (en) | Anti-freeze proteins, their production and use | |
DE60036555D1 (de) | Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter | |
WO2000018909A3 (fr) | Acides nucleiques et proteines provenant de cenarchaeum symbiosum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1997945549 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 1997945549 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997945549 Country of ref document: EP |